Change history
04 June 2024
A Correction to this paper has been published: https://doi.org/10.1038/s41587-024-02296-y
References
Ezell, S. How Japan squandered its biopharmaceutical competitiveness: a cautionary tale. https://itif.org/publications/2022/07/25/how-japan-squandered-its-biopharmaceutical-competitiveness-a-cautionary-tale/ (Information Technology and Innovation Foundation, 2022).
Vital Transformation, LLC. The US Ecosystem for Medicines. https://vitaltransformation.com/wp-content/uploads/2022/12/Where-do-new-medicines-originate_FINAL2022_12_05.pdf (2022).
Venture Enterprise Center. VEC yearbook 2023. https://www.vec.or.jp/en (2023).
Startup Genome. The global startup ecosystem report, GSER 2021. https://startupgenome.com/report/gser2021 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kessel, M., Vickrey, C. Why Japan lacks a vibrant biotech industry. Nat Biotechnol 42, 694 (2024). https://doi.org/10.1038/s41587-024-02227-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-024-02227-x
- Springer Nature America, Inc.